Skip to main content
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Current issue
Archive
Authors
About
Podcasts
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Current issue
Archive
Authors
About
Podcasts
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 76, Issue 7
Long-term safety of tofacitinib for the treatment of rheumatoid arthritis up to 8.5 years: integrated analysis of data from the global clinical trials
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
PDF +
Supplementary
Material
Clinical and epidemiological research
Extended report
Long-term safety of tofacitinib for the treatment of rheumatoid arthritis up to 8.5 years: integrated analysis of data from the global clinical trials
Online download statistics by month:
Online download statistics by month: January 2017 to October 2024
Abstract
Full
Pdf
Jan 2017
298
43
79
Feb 2017
789
1260
1124
Mar 2017
7
785
506
Apr 2017
2
582
366
May 2017
1
456
297
Jun 2017
200
844
396
Jul 2017
615
615
359
Aug 2017
401
401
284
Sep 2017
356
358
217
Oct 2017
405
404
221
Nov 2017
406
407
219
Dec 2017
346
348
131
Jan 2018
437
438
173
Feb 2018
415
394
180
Mar 2018
473
469
156
Apr 2018
452
454
136
May 2018
352
355
115
Jun 2018
424
427
114
Jul 2018
421
420
173
Aug 2018
474
475
167
Sep 2018
476
476
166
Oct 2018
517
517
176
Nov 2018
408
418
176
Dec 2018
304
305
107
Jan 2019
417
419
161
Feb 2019
507
514
159
Mar 2019
490
478
171
Apr 2019
466
444
141
May 2019
426
407
112
Jun 2019
404
388
109
Jul 2019
284
266
106
Aug 2019
212
195
88
Sep 2019
226
203
93
Oct 2019
270
237
101
Nov 2019
223
205
123
Dec 2019
183
177
88
Jan 2020
234
214
98
Feb 2020
199
178
110
Mar 2020
206
191
89
Apr 2020
204
186
194
May 2020
192
164
98
Jun 2020
168
146
125
Jul 2020
174
158
97
Aug 2020
166
143
102
Sep 2020
192
163
117
Oct 2020
235
214
123
Nov 2020
163
140
91
Dec 2020
171
149
62
Jan 2021
171
150
84
Feb 2021
262
234
116
Mar 2021
207
179
91
Apr 2021
164
137
72
May 2021
166
133
65
Jun 2021
143
112
67
Jul 2021
119
119
70
Aug 2021
147
146
78
Sep 2021
160
160
68
Oct 2021
188
157
73
Nov 2021
180
150
83
Dec 2021
160
142
51
Jan 2022
217
170
82
Feb 2022
172
155
55
Mar 2022
172
148
74
Apr 2022
235
215
45
May 2022
288
257
90
Jun 2022
206
195
53
Jul 2022
222
178
44
Aug 2022
236
195
57
Sep 2022
243
195
60
Oct 2022
252
199
51
Nov 2022
267
210
72
Dec 2022
202
160
45
Jan 2023
227
206
50
Feb 2023
245
207
58
Mar 2023
330
279
84
Apr 2023
247
201
61
May 2023
209
168
69
Jun 2023
227
198
64
Jul 2023
198
186
68
Aug 2023
201
174
32
Sep 2023
231
219
29
Oct 2023
380
336
49
Nov 2023
400
345
37
Dec 2023
385
273
54
Jan 2024
148
117
137
Feb 2024
177
161
38
Mar 2024
308
261
119
Apr 2024
269
241
52
May 2024
328
290
55
Jun 2024
193
163
28
Jul 2024
233
199
57
Aug 2024
204
165
48
Sep 2024
142
118
38
Oct 2024
136
115
59
Total
25588
26348
11728
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?